Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate

Clinical trial NCT01692652 · COMPLETED

Trial details

NCT number: NCT01692652
Sponsor: Yonsei University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)

Start date: 2012-08-01
Primary completion: 2013-03-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.